Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.31 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.31 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL16990216 | 0.93 | TSHR (0.57) | TSHRALDH1A1CA2CA9TP53 | |
| SCHEMBL10766982 | 0.92 | TSHR (0.63) | TSHRALDH1A1CA2CA9LMNA | |
| Dimethyl Sulfone SCHEMBL3793667 | 0.86 | TSHR (0.71) | TSHRALDH1A1CA2CA9 | |
| SCHEMBL27749745 | 0.85 | TSHR (0.55) | TSHRALDH1A1CA2CA9LMNA | |
| Sulfuric Acid SCHEMBL3084115 | 0.84 | TSHR (0.70) | TSHRALDH1A1TP53LMNAZDHHC20 | |
| SCHEMBL9720004 | 0.83 | TSHR (0.67) | TSHRALDH1A1CA2CA9 | |
| Sulfuric Acid SCHEMBL3079655 | 0.82 | TSHR (0.68) | TSHRALDH1A1TP53LMNAZDHHC20 | |
| Methyl Alcohol SCHEMBL8944947 | 0.82 | — | — | |
| SCHEMBL1871536 | 0.82 | TSHR (1.00) | TSHRALDH1A1 | |
| SCHEMBL7040 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100285601-A1 | METHOD OF ELECTRICALLY DETECTING A NUCLEIC ACID MOLECULE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-11-11 | — | — | US | claimed |
| WO-2009041917-A1 | METHOD OF ELECTRICALLY DETECTING A NUCLEIC ACID MOLECULE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-04-02 | — | — | WO | claimed |
| EP-3306732-B1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS INC (JP) | 2025-06-25 | — | — | EP | disclosed |
| WO-2025094896-A1 | BATTERY | 住友化学株式会社 | 2025-05-08 | — | — | WO | disclosed |
| WO-2025057907-A1 | ELECTROLYTE COMPOSITION AND BATTERY | 住友化学株式会社 | 2025-03-20 | — | — | WO | disclosed |
| CN-119343801-A | Electrochemical device and electrolyte for electrochemical device | 株式会社力森诺科 | 2025-01-21 | — | — | CN | disclosed |
| WO-2023127227-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | パナソニックＩＰマネジメント株式会社 | 2023-07-06 | — | — | WO | disclosed |
| CN-115974730-A | Method for synthesizing organic sulfate by persulfate | 湖南大学 | 2023-04-18 | — | — | CN | disclosed |
| CN-115632162-A | Electrolyte and battery | 珠海冠宇电池股份有限公司 | 2023-01-20 | — | — | CN | disclosed |
| EP-3343687-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES AND LITHIUM SECONDARY BATTERY COMPRISING THE SAME | MITSUI CHEMICALS INC (JP) | 2021-02-24 | — | — | EP | disclosed |
| US-10323050-B2 | Non-aqueous electrolyte solution for battery, novel compound, polyelectrolyte, and lithium secondary battery | MITSUI CHEMICALS, INC. (JP) | 2019-06-18 | — | — | US | disclosed |
| WO-2007053935-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMERIC BINDERS WITH NON-HYDROLYSABLE COVALENT BONDS AND THEIR USE IN TREATING CELIAC DISEASE | UNIVERSITE DE MONTREAL (CA) | 2007-05-18 | — | — | WO | disclosed |
| US-20060029568-A1 | Administering a polymer with pendant acid functional groups or a salt with a pharmaceutically acceptable cation; free of acid anhydride groups; antidiarrhea agents | GENZYME CORPORATION (US) | 2006-02-09 | — | — | US | disclosed |
| US-6890523-B2 | Anionic polymers as toxin binders and antibacterial agents | GENZYME CORPORATION (US) | 2005-05-10 | — | — | US | disclosed |
| US-20030138397-A1 | Anionic polymers as toxin binders and antibacterial agents | GELTEX PHARMACEUTICALS, INC. | 2003-07-24 | — | — | US | disclosed |
| US-6517827-B1 | Polystyrene sulfonate polymer; Clostridium difficile | GELTEX PHARMACEUTICALS, INC. | 2003-02-11 | — | — | US | disclosed |
| US-6517826-B1 | Polystyrene sulfonate polymer; Clostridium difficile | GELTEX PHARMACEUTICALS, INC. | 2003-02-11 | — | — | US | disclosed |
| EP-1189622-A2 | ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS | Geltex Pharmaceuticals, Inc. (US) | 2002-03-27 | — | — | EP | disclosed |
| US-6290946-B1 | ADMINISTERING TO THE ANIMAL A THERAPEUTICALLY EFFECTIVE AMOUNT OF A POLYMER HAVING A PLURALITY OF PENDANT ACID FUNCTIONAL GROUPS WHICH ARE DIRECTLY ATTACHED TO THE POLYMER BACKBONE OR ATTACHED TO THE POLYMER BACKBONE BY A SPACER GROUP. | GELTEX PHARMACEUTICALS, INC. | 2001-09-18 | — | — | US | disclosed |
| WO-2000069428-A2 | ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 2000-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060029568-A1 | Administering a polymer with pendant acid functional groups or a salt with a pharmaceutically acceptable cation; free of acid anhydride groups; antidiarrhea agents | DDOST, DNPEP, IDUA | TSHR 821/4885ALDH1A1 1727/4885CA2 6/4885 |
| US-10323050-B2 | Non-aqueous electrolyte solution for battery, novel compound, polyelectrolyte, and lithium secondary battery | KCNA1, LPO, KCNB1 | TSHR 2730/4885ALDH1A1 939/4885CA2 868/4885 |
| US-20030138397-A1 | Anionic polymers as toxin binders and antibacterial agents | MSN, ANTXR2, PNKP | TSHR 1345/4885ALDH1A1 4470/4885CA2 2499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.